Stevanato Group S.p.a Stock News

MILAN (Reuters) – Italian vaccine vial maker Stevanato on Tuesday said it expected double-digit growth for revenue and core profits this year after beating its forecast for 2021 financial results.

Stevanato Group S.p.A. (STVN) CEO Franco Moro on Q4 2021 Results - Earnings Call Transcript

Stevanato Group press release (STVN): Q4 GAAP EPS of €0.17.Revenue of €232.6M (+12.5% Y/Y).The company established FY2022 guidance and expects revenue in the range of €935M to…

Companies Reporting Before The Bell • Babcock & Wilcox (NYSE: BW ) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. • Desktop Metal (NYSE: DM ) is projected to report quarterly loss at $0.09 per share on revenue of $49.58 million. • Stevanato Group (NYSE: STVN ) is projected to report quarterly earnings at $0.11 per share on revenue of $244.99 million. • CPI Card (NASDAQ: PMTS ) is likely to report quarterly earnings at $0.35 per share on revenue of $94.40 million. • CareMax (NASDAQ: CMAX ) is likely to report quarterly loss at $0.06 per share on revenue of $118.44 million. • Matinas BioPharma Hldgs (AMEX: MTNB ) is expected to report quarterly loss at $0.03 per share on revenue of $470.00 thousand. • Nuvei (NASDAQ: NVEI ) is likely to report quarterly earnings at $0.57 per share on revenue of $264.56 million. • Gaotu Techedu (NYSE: GOTU ) is likely to report quarterly earnings at $0.26 per share on revenue of $333.80 million. • OptiNose (NASDAQ: OPTN ) is estimated to report quarterly loss at $0.

Stevanato (STVN) said its unit OMPI of America signed an agreement to support the Biomedical Advanced Research and Development Authority (BARDA), pursuant to which BARDA will provide up…

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Q4 & YE 2021 Earnings notification

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Q4 & YE 2021 Earnings notification

Stevanato Group S.p.A. (STVN) CEO Franco Moro on Q3 2021 Results - Earnings Call Transcript

PIOMBINO DESE (PD), Italy--(BUSINESS WIRE)--Stevanato Group (NYSE:STVN) (“the Company”), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotec

PIOMBINO DESE (PD), Italy--(BUSINESS WIRE)--Stevanato Group (NYSE:STVN), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sci

Stevanato Group S.p.A. (STVN) CEO Franco Moro on Q2 2021 Results - Earnings Call Transcript

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,